在克服癌症转移的LncRNA MALAT1信号通路和临床应用
Madineh Mazarei1, Venus Shahabi Rabori2, Nazila Ghasemi3
1Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Clinical and experimental medicine
|September 11, 2023
概括
像MALAT1这样的长非编码RNA (lncRNA) 在癌症中至关重要. 这项研究探讨了MALAT1
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 由于高死亡率和复杂的信号通路,癌症治疗面临着挑战.
- 异常基因表达是癌症的标志,需要针对性治疗.
- 长非编码RNAs (lncRNAs) 正在成为基因表达的关键调节者和潜在的治疗点.
研究的目的:
- 研究 lncRNA MALAT1 在癌症转移中的功能性作用.
- 为了阐明MALAT1和细胞信号通路之间的相互作用.
- 突出MALAT1作为癌症治疗的潜在治疗点.
主要方法:
- 文献审查和对MALAT1.1现有研究的分析.
- 检查MALAT1在基因表达,RNA处理和表观遗传控制中的参与.
- 对MALAT1与癌细胞转移,入侵,自和扩散的关联进行分析.
主要成果:
- 高MALAT1表达与癌细胞转移和入侵的增加有关.
- 马拉特1影响癌细胞内的多种信号通路和微RNA (miRNA).
- 马拉特1在调节与癌症进展相关的基因表达方面发挥着重要作用.
结论:
- 马拉特1涉及到驱动癌症转移的关键过程.
- 了解MALAT1与信号通路的相互作用为癌症治疗提供了新的途径.
- 向MALAT1为诊断和治疗各种恶性瘤提供了一个有希望的策略.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


